These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 14990658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
    Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE.
    J Clin Oncol; 2003 Sep 01; 21(17):3262-8. PubMed ID: 12947061
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 01; 10(1):1-4. PubMed ID: 18289459
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study on mitoxantrone contained regimen for treatment of newly diagnosed childhood acute lymphoblastic leukemia].
    Wang WQ, Liu XY, Liu LQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct 01; 29(5):602-3. PubMed ID: 16137060
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia.
    Bakhshi S, Sethuraman G, Singh MK, Arya LS.
    Pediatr Dermatol; 2005 Oct 01; 22(6):543-5. PubMed ID: 16354258
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M.
    Klin Padiatr; 2005 Oct 01; 217(6):310-20. PubMed ID: 16307416
    [Abstract] [Full Text] [Related]

  • 12. Overt testicular disease (OTD) at diagnosis is not associated with a poor prognosis in childhood acute lymphoblastic leukemia: results of the EORTC CLG Study 58881.
    Sirvent N, Suciu S, Bertrand Y, Uyttebroeck A, Lescoeur B, Otten J.
    Pediatr Blood Cancer; 2007 Sep 01; 49(3):344-8. PubMed ID: 16358303
    [Abstract] [Full Text] [Related]

  • 13. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA, Hassenpflug WA, zur Stadt U, Escherich G, Janka G, Kabisch H.
    Haematologica; 2005 Dec 01; 90(12):1701-3. PubMed ID: 16330449
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

  • 15. [Progress in the treatment of acute lymphoid leukemia in children. Experience of the GATLA/GLATHEM, 1967-1987].
    Garay G, Aversa LA, Svarch E, Sackmann Muriel F, Drelichman G, Santarelli MT, Jiménez E, Divito JM, Pavlovsky S, Eppinger Helft M.
    Sangre (Barc); 1989 Apr 15; 34(2):136-43. PubMed ID: 2667171
    [No Abstract] [Full Text] [Related]

  • 16. Childhood acute lymphoblastic leukemia presenting with severe hepatic dysfunction.
    Belgaumi AF, Hudson MM.
    Med Pediatr Oncol; 2001 Aug 15; 37(2):142-4. PubMed ID: 11496355
    [No Abstract] [Full Text] [Related]

  • 17. [21 years in the treatment of acute lymphoblastic leukemias in children (1967-1987)].
    Ortega JJ, Javier G, Olivé T, Montagut JM.
    Sangre (Barc); 1988 Oct 15; 33(5):372-82. PubMed ID: 3073534
    [No Abstract] [Full Text] [Related]

  • 18. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
    Plasschaert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES.
    Cancer Treat Rev; 2004 Feb 15; 30(1):37-51. PubMed ID: 14766125
    [Abstract] [Full Text] [Related]

  • 19. Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions.
    Hochberg J, Cairo MS.
    Pediatr Blood Cancer; 2009 Dec 15; 53(6):917-9. PubMed ID: 19672977
    [No Abstract] [Full Text] [Related]

  • 20. In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
    Lönnerholm G, Thörn I, Sundström C, Frost BM, Abrahamsson J, Behrendtz M, Heldrup J, Jacobsson S, Li A, Olofsson T, Porwit A, Söderhäll S, Larsson R, Forestier E.
    Leuk Res; 2009 Jan 15; 33(1):46-53. PubMed ID: 18639340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.